Literature DB >> 33815742

Perspectives on Care for Late-Stage Parkinson's Disease.

Kristina Rosqvist1, Marianne Kylberg2, Charlotte Löfqvist2, Anette Schrag3, Per Odin1,4, Susanne Iwarsson2.   

Abstract

In the late stage of Parkinson's disease (PD), there is an increasing disease burden not only for the patients but also for their informal caregivers and the health and social services systems. The aim of this study was to explore experiences of late-stage PD patients' and their informal caregivers' satisfaction with care and support, in order to better understand how they perceive the treatment and care they receive. This qualitative substudy was part of the longitudinal European multicentre Care of Late Stage Parkinsonism (CLaSP) project. Individual semistructured interviews were conducted with patients (n = 11) and informal caregivers (n = 9) in Sweden. Data were analysed through the content analysis technique. The final analyses generated one main category: "We are trying to get by both with and without the formal care" and five subcategories: "Availability of health care is important for managing symptoms and everyday life"; "Dependence on others and scheduled days form everyday life"; "There is a wish to get adequate help when it is needed"; "Mixed feelings on future housing and respite care"; and "Family responsibility and loyalty for a functioning everyday life". Having regular contact with PD-specialised health care was perceived as important. Greater access to physiotherapy was wished for. Maintaining autonomy was perceived as important by patients, in both home health care and a future residential care setting. Responsibility and loyalty between spouses and support from children enabled everyday life to carry on at home, indicating a vulnerability for those without an informal caregiver. The results suggest that regular access to PD-specialised health care is important and that a specialised and multidisciplinary approach to the management of PD symptomatology is likely necessary. Non-PD-specialised staff in home health care and residential care facilities should regularly be given opportunities to obtain PD-specific education and information.
Copyright © 2021 Kristina Rosqvist et al.

Entities:  

Year:  2021        PMID: 33815742      PMCID: PMC7987470          DOI: 10.1155/2021/9475026

Source DB:  PubMed          Journal:  Parkinsons Dis        ISSN: 2042-0080


  34 in total

1.  Three approaches to qualitative content analysis.

Authors:  Hsiu-Fang Hsieh; Sarah E Shannon
Journal:  Qual Health Res       Date:  2005-11

2.  Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.

Authors:  Katherine A Grosset; Donald G Grosset
Journal:  Mov Disord       Date:  2005-05       Impact factor: 10.338

3.  EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.

Authors:  Haidar S Dafsari; Pablo Martinez-Martin; Alexandra Rizos; Maja Trost; Maria Gabriela Dos Santos Ghilardi; Prashanth Reddy; Anna Sauerbier; Jan Niklas Petry-Schmelzer; Milica Kramberger; Robbert W K Borgemeester; Michael T Barbe; Keyoumars Ashkan; Monty Silverdale; Julian Evans; Per Odin; Erich Talamoni Fonoff; Gereon R Fink; Tove Henriksen; Georg Ebersbach; Zvezdan Pirtošek; Veerle Visser-Vandewalle; Angelo Antonini; Lars Timmermann; K Ray Chaudhuri
Journal:  Mov Disord       Date:  2019-02-04       Impact factor: 10.338

4.  Perspectives on Parkinson disease care in Dutch nursing homes.

Authors:  Anouke van Rumund; Nico Weerkamp; Gerrit Tissingh; Sytse U Zuidema; Raymond T Koopmans; Marten Munneke; Petra J E Poels; Bastiaan R Bloem
Journal:  J Am Med Dir Assoc       Date:  2014-06-28       Impact factor: 4.669

5.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Dopaminergic Effect on Non-Motor Symptoms in Late Stage Parkinson's Disease.

Authors:  Kristina Rosqvist; Per Odin; Peter Hagell; Susanne Iwarsson; Maria H Nilsson; Alexander Storch
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

8.  Experience of care for Parkinson's disease in European countries: a survey by the European Parkinson's Disease Association.

Authors:  A Schrag; K Khan; S Hotham; R Merritt; O Rascol; L Graham
Journal:  Eur J Neurol       Date:  2018-08-16       Impact factor: 6.089

Review 9.  Levodopa therapy for Parkinson disease: A look backward and forward.

Authors:  Peter A LeWitt; Stanley Fahn
Journal:  Neurology       Date:  2016-04-04       Impact factor: 9.910

10.  Experiences of health services and unmet care needs of people with late-stage Parkinson's in England: A qualitative study.

Authors:  Joy Read; Sarah Cable; Charlotte Löfqvist; Susanne Iwarsson; Gergely Bartl; Anette Schrag
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

View more
  4 in total

1.  Transitions and challenges for people with Parkinson's and their family members: A qualitative study.

Authors:  Joy Read; Rachael Frost; Kate Walters; Remco Tuijt; Jill Manthorpe; Bev Maydon; Jennifer Pigott; Anette Schrag; Nathan Davies
Journal:  PLoS One       Date:  2022-07-18       Impact factor: 3.752

Review 2.  The subjective experience of family caregivers of people living with Parkinson's disease: a meta-ethnography of qualitative literature.

Authors:  Yiping Chen; Wentao Zhou; Liyuan Hou; Xianhui Zhang; Qiaohong Wang; Jing Gu; Ru Zhang; Hui Yang
Journal:  Aging Clin Exp Res       Date:  2021-10-14       Impact factor: 4.481

Review 3.  Personalized Care in Late-Stage Parkinson's Disease: Challenges and Opportunities.

Authors:  Margherita Fabbri; Miguel Coelho; Michela Garon; Roberta Biundo; Tiago A Mestre; Angelo Antonini
Journal:  J Pers Med       Date:  2022-05-18

4.  Caregiver Burden and Quality of Life in Late Stage Parkinson's Disease.

Authors:  Kristina Rosqvist; Anette Schrag; Per Odin
Journal:  Brain Sci       Date:  2022-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.